SYS6043, a B7-H3 targeting antibody-drug conjugates in patients with advanced gynecologic cancers: A phase 1/2, first-in-human study

Gynecologic Oncology 2026

View at publisher

Authors: Jing Zuo, Ying Xin, Shuo Shi, Lingying Wu

DOI: 10.1016/j.ygyno.2026.01.057

Cited by: 1

Fields of Study & Subjects

HER2/EGFR in Cancer Research Advanced Breast Cancer Therapies Endometrial and Cervical Cancer Treatments